This report discusses the need for an integrated and cyclical approach to managing
health technology in order to mitigate clinical and financial risks, and ensure acceptable
value for money. The analysis considers how health systems and policy makers should
adapt in terms of development, assessment and uptake of health technologies. The first
chapter provides an examination of adoption and impact of medical technology in the
past and how health systems are preparing for continuation of such trends in the future.
Subsequent chapters examine the need to balance innovation, value, and access for
pharmaceuticals and medical devices, respectively, followed by a consideration of
their combined promise in the area of precision medicine. The final chapter examines
how health systems can make better use of health data and digital technologies. The
report focuses on opportunities linked to new and emerging technologies as well as
current challenges faced by policy makers, and suggests a new governance framework
to address these challenges.
À lire également : Les nouvelles technologies de santé - Synthèse. Ce document est une traduction en français du chapitre 1 du rapport New Health Technologies: Managing Access, Value and Sustainability, publié exclusivement en anglais.
Regarder la présentation en français faite par l'OCDE lors de l'atelier de l'Ajef pour la sortie du rapport :
The OECD High Level Policy Forum on "Health in the 21st Century: Data, Policy, and Digital Technology" took place on 21 November 2019 in Copenhagen, Denmark. Visit www.oecd.org/health/health-21-century for further information.